Assessment of Implantable Cardioverter-Defibrillator Used in Heart Failure with Reduced Ejection Fraction as Primary Prevention in an Underserved Population

被引:0
|
作者
Lu, Yifan [1 ]
Wan, Ningxin [1 ]
Madan, Nidhi [1 ]
Hovnanians, Ninel [1 ]
Diaz, Juan Carlos Ruiz [1 ]
Christia, Panagiota [1 ]
Faillace, Robert [1 ]
机构
[1] Albert Einstein Coll Med, Jacobi Med Ctr, Bronx, NY 10467 USA
关键词
THERAPY;
D O I
10.1007/s11606-018-4544-1
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
引用
收藏
页码:1854 / 1856
页数:3
相关论文
共 50 条
  • [21] Update on primary prevention implantable cardioverter-defibrillator therapy
    Epstein A.E.
    Current Cardiology Reports, 2009, 11 (5) : 335 - 342
  • [22] IMPACT OF EJECTION FRACTION ON SURVIVAL BENEFIT WITH IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR THERAPY
    Issa, Meltiady
    Sipahi, Ilke
    Chaudhry, Sunit-Preet
    Fang, James C.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 57 (14) : E37 - E37
  • [23] Implantable cardioverter-defibrillator treatment and resynchronisation in heart failure
    Linde, C
    HEART, 2004, 90 (02) : 231 - 234
  • [24] Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure
    Bardy, GH
    Lee, KL
    Mark, DB
    Poole, JE
    Packer, DL
    Boineau, R
    Domanski, M
    Troutman, C
    Anderson, J
    Johnson, G
    McNulty, SE
    Clapp-Channing, N
    Davidson-Ray, LD
    Fraulo, ES
    Fishbein, DP
    Luceri, RM
    Ip, JH
    NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (03): : 225 - 237
  • [25] Outcomes of Heart Failure With Reduced Ejection Fraction Status Post Implantable Cardioverter-Defibrillator Presenting with HFrEF Exacerbation With Versus Without Atrial Fibrillation
    Arshad, Hassaan
    Butt, Sara
    Feurdean, Mirela
    Solanki, Pallavi
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 74 (13) : B334 - B334
  • [26] Imaging modality for left ventricular ejection fraction estimation and effect of implantable cardioverter-defibrillator on mortality in patients with heart failure
    Smith, Alexander
    Kumar, Sant
    Moore, Hans J.
    Iskandrian, Ami E.
    Nanda, Navin C.
    Raman, Venkatesh K.
    Singh, Steven
    Fletcher, Ross D.
    Deedwania, Prakash
    Fonarow, Gregg C.
    Greenberg, Michael D.
    Ahmed, Ali
    Lam, Phillip H.
    HEART RHYTHM, 2023, 20 (06) : 886 - 890
  • [27] Association Between Comorbidities and Outcomes in Heart Failure Patients With and Without an Implantable Cardioverter-Defibrillator for Primary Prevention
    Khazanie, Prateeti
    Hellkamp, Anne S.
    Fonarow, Gregg C.
    Bhatt, Deepak L.
    Masoudi, Frederick A.
    Anstrom, Kevin J.
    Heidenreich, Paul A.
    Yancy, Clyde W.
    Curtis, Lesley H.
    Hernandez, Adrian F.
    Peterson, Eric D.
    Al-Khatib, Sana M.
    Journal of the American Heart Association, 2015, 4 (08): : e002061
  • [28] Feasibility and First Results of Heart Failure Monitoring Using the Wearable Cardioverter-Defibrillator in Newly Diagnosed Heart Failure with Reduced Ejection Fraction
    Hillmann, Henrike Aenne Katrin
    Hohmann, Stephan
    Mueller-Leisse, Johanna
    Zormpas, Christos
    Eiringhaus, Joerg
    Bauersachs, Johann
    Veltmann, Christian
    Duncker, David
    SENSORS, 2021, 21 (23)
  • [29] New york heart association functional class does not modify the effect of an implantable cardioverter-defibrillator in nonischemic heart failure with reduced ejection fraction: a DANISH substudy
    Butt, J.
    Karacan, M. N.
    Doi, S. N.
    Yafasova, A.
    Svendsen, J. H.
    Nielsen, J. C.
    Eske-Bruun, N.
    Gustafsson, F.
    Pehrson, S.
    Vraa, S.
    Videbaek, L.
    Haarbo, J.
    Schou, M.
    Thune, J-J
    Koeber, L.
    EUROPEAN JOURNAL OF HEART FAILURE, 2024, 26 : 25 - 25
  • [30] Compelling First-Line Drug and Device Therapies for the Prevention of Sudden Death in Patients With Chronic Heart Failure and a Reduced Ejection Fraction Who Are Candidates for an Implantable Cardioverter-Defibrillator
    Packer, Milton
    CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2019, 12 (06):